Explore various ARPA-H funding opportunities that include research in imaging data exchange, advancing clinical trial readiness, and the emerging health innovators initiative.
Funding opportunities are available across a variety of fields and specialties, ranging from digital health technology, to tobacco, alcohol, and cannabis policy, to environmental health and more.
Take a look at several foundation funding opportunities provided by the advancement team. These opportunities come from foundations such as the AFAR, Glenn Foundation and the Whitehall Foundation.
The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.
Prenatal exposure to ozone pollution could be harming the cognitive development of unborn children, according to new interdisciplinary research from the University of Utah. The peer-reviewed study found a strong...
The therapy increases the amount of blood the heart can pump and dramatically improves survival, in what a paper describing the results calls “an unprecedented recovery of cardiac function.”
Researchers have found that some coronavirus genes don’t produce a working protein, but nevertheless appear to give the viruses an evolutionary leg up. Their work investigating how these mystery genes...
